Course unit title Level of course unit Course unit code Type of course unit Semester of course unit Local credit ECTS credit Syllabus
SPECIAL FIELD COURSE 1 Third cycle HKK 751 3 5.00 5.00 Print
   
Description of course unit
Prerequisites and course requisities Cumpulsory and elective courses.
Language of instruction Turkish
Coordinator Assoc. Prof. Dr. Cengiz GÜL
Lecturer(s) All related lecturers
Teaching assitant(s) -
Mode of delivery Verbal teaching
Course objective Reading and writing on metarial expert area.
Course description Students focuse, literature reseacrh and make an academic material.

Course contents
1 Determining of subject
2 Research
3 Writing
4 Submission
5 Evolution
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Learning outcomes of the course unit
1 Comprehensive literature review possible
2 Written and oral presentation skills are gained
3 The results of a research and examination can be evaluated and interpreted in detail
4 The ability to do theoretical and practical work on a topic to be chosen
5 The skill of evaluating advanced knowledge and skills in the field with a critical approach is gained.
6 Have the legal knowledge required by the field.
7
8
9
10

*Contribution level of the course unit to the key learning outcomes
1 To learn preclinical pharmaceutical R&D activities and methods and to manage the process,
2 Being able to use devices involved in pharmaceutical R&D activities,
3 To carry out new drug research and development studies using drug administration and research techniques,
4 Obtaining product-oriented results from pharmaceutical R&D activities,
5 Obtaining product-oriented results from pharmaceutical R&D activities,
6 Working towards the needs of human, veterinary, agricultural and environmental health pharmaceutical industry,
7 Learning chemical synthesis methods and developing products through synthesis,
8 To learn the basic principles of bioinformatics and to perform statistical analyses,
9 Obtaining pharmaceutical raw materials from herbal and other sources and converting them into formulations,
10 To be able to monitor therapeutic drugs with pharmacogenetic and pharmacokinetic analyses,
11 To learn analysis methods and method validations for banned substances,
12 To learn in vivo and in vitro methods used in neuropsychiatric diseases,
13 To be able to analyze articles and studies related to pharmaceutical R&D,
14 Being able to make scientific projects, presentations and publications,
15 To recognize the quality systems involved in the pharmaceutical R&D process,
16 To acquire a culture of teamwork in scientific studies and to be consistent in human relations,
17 Conducting work within the framework of ethical values ??and managing ethics committee application processes,
18 Ability to lead in environments that require solving unique and interdisciplinary problems
19 To be able to follow innovations in the pharmaceutical R&D process and to gain lifelong learning habits,
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Number of stars refer to level of contribution from 1 (the least) to 5 (the most)

Planned learning activities, teaching methods and ECTS work load
  Quantity Time (hour) Quantity*Time (hour)
Lectures (face to face teaching) 14 3 42
Study hours out of classroom (study before and after the class) 14 4 56
Homework 1 10 10
Presentation / seminar 0 0 0
Quiz 0 0 0
Preparation for midterm exams 1 10 10
Midterm exams 1 3 3
Project (term paper) 0 0 0
Laboratuar 0 0 0
Field study 0 0 0
Preparation for final exam 1 3 3
Final exam 1 3 3
Research 0 0 0
Total work load     127
ECTS     5.00

Assessment methods and criteria
Evaluation during semester Quantity Percentage
Midterm exam 0 40
Quiz 0 0
Homework 0 0
Semester total   40
Contribution ratio of evaluation during semester to success   40
Contribution ratio of final exam to success   60
General total   100

Recommended and required reading
Textbook All literature
Additional references

Files related to the course unit